## Abstract A large number of women survive a diagnosis of breast cancer. Knowledge of their risk of developing a new primary cancer is important not only in relation to potential side effects of their cancer treatment, but also in relation to the possibility of shared etiology with other types of
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer
โ Scribed by Aditya Bardia; Erin T. Arieas; Zhe Zhang; Andrew DeFilippis; Karineh Tarpinian; Stacie Jeter; Anne Nguyen; N. Lynn Henry; David A. Flockhart; Daniel F. Hayes; Jill Hayden; Anna Maria Storniolo; Deborah K. Armstrong; Nancy E. Davidson; John Fetting; Pamela Ouyang; Antonio C. Wolff; Roger S. Blumenthal; M. Dominique Ashen; Vered Stearns
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 469 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Elevated blood pressure has been proposed to be a risk factor for breast cancer but the results remain controversial. In this study, the incidence of breast cancer among 9,112 postmenopausal, hypertensive women included in the communityโbased hypertension register of the North Karelia p
## Abstract Obesity, alcohol consumption, physical inactivity and postmenopausal hormone use are known modifiable risk factors for breast cancer. We aim to measure incidence rates of breast cancer for women with favorable levels on all 4 risk factors (BMI โค 30 kg/m^2^, alcohol <1 drink/week, physic
## Abstract Although several risk factors are common to endometriosis and breast cancer, the results of observational studies of an association have so far been inconsistent. We evaluated the relationship between endometriosis and breast cancer on the basis of data on selected cancers and medical h
## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)โpositive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi